Player is loading...

Embed

Copy embed code

Transcriptions

Note: this content has been automatically generated.
00:00:00
as for you right yes oh the floor yours thank you so my name is mark i'm the uh so you were still looks
00:00:10
and we have developed a new technology was the relation of medical instruments
00:00:16
do you know that ten percent of the patient in
00:00:18
developing countries get a surgical site infection after surgery
00:00:23
this is five times more important than the rates we have here in your
00:00:29
they are several causes of surgical site infection but it is estimated that every two
00:00:34
minutes someone died was that because of the use of non sterile instruments
00:00:41
one of the reason of this is because of the machines that can still relies
00:00:46
they are very big they are heavy and to stay relies instrument for one single surgery you need
00:00:53
fifty meters of water and the same energy use for your smart phone you know you're
00:01:00
this is why we developed our own theory lies are based on
00:01:03
another technology mainly ozone in use by u. v. radiation
00:01:08
and with our technology we can do with one
00:01:12
leader of water two hundred uh surgeries
00:01:17
what targeting to different market so the first one is
00:01:21
hospitals in developing countries or this market will have
00:01:25
one product as that will be sold at fifteen k. but we are also interested in another segment
00:01:32
uh that our medical and harmony colour pieces like that what pieces of
00:01:36
it are we not really is uh and well the logistics
00:01:40
and for that uh market will have a smaller product that will be sold at five q.
00:01:47
in the management team that there is my seven zero i graduated from e. p. f. l. in life sciences
00:01:53
uh be forced to reduce i worked for two years at may twenty h. then
00:01:57
we have luca is my seat your he's in charge of the c. certification
00:02:01
he also come from e. p. f. l. and michael also from e. p. f. l. in life sciences
00:02:07
uh he's our c. f. o. and in our team we have ten more engineers
00:02:13
and in our advisory board we have a max was there was
00:02:17
my former director at may twenty and almost our main investor
00:02:22
this is what we achieved so so far we already raise one million we protected our technology was two buttons
00:02:29
and uh last months we in style our first machine in a hospital income one
00:02:36
for uh in the scope of a clinical trial now our product is ready
00:02:40
for the seat education that will take place a beginning of next year
00:02:45
and now i'm here to raise and fight investors well looking for one billion by the end
00:02:52
of this year and this money will allow us to get the c. certification to
00:02:58
launch our product on the market and to develop our second product thank you for athens thank you
00:03:09
are you also subsidy the use of he'll standardisation does the bus
00:03:18
ah technology it's a it's a it's a low temperature so this why uh there was
00:03:24
a big uh uh and we we we get serious plastic an electronic so

Share this talk: 


Conference Program

elthera
Oct. 25, 2017 · 11:12 a.m.
257 views
SunRegen
Oct. 25, 2017 · 11:16 a.m.
329 views
GRATXRAY
Oct. 25, 2017 · 11:20 a.m.
272 views
certus diagnostics
Oct. 25, 2017 · 11:29 a.m.
224 views
Trackcath?
Oct. 25, 2017 · 11:32 a.m.
retinai
Oct. 25, 2017 · 11:36 a.m.
334 views
scailyte
Oct. 25, 2017 · 11:40 a.m.
241 views
Ophtho robotics
Oct. 25, 2017 · 11:45 a.m.
234 views
Dicronis
Oct. 25, 2017 · 11:49 a.m.
318 views
IDUN
Oct. 25, 2017 · 11:53 a.m.
198 views
steriLux
Oct. 25, 2017 · 11:56 a.m.
144 views
T-CHAIR
Oct. 25, 2017 · 12:01 p.m.
129 views
AESYRA
Oct. 25, 2017 · 12:04 p.m.
476 views
FlavorWiki
Oct. 25, 2017 · 12:09 p.m.
367 views
Algrano
Oct. 25, 2017 · 12:12 p.m.
498 views
BioSens
Oct. 25, 2017 · 12:17 p.m.
171 views
Farmerline
Oct. 25, 2017 · 12:21 p.m.
104 views

Recommended talks

Swisens
Oct. 25, 2017 · 11:56 a.m.
Pitch of Velohub (Interdis)
Oct. 25, 2016 · 12:33 p.m.